| pubmed-article:21324516 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21324516 | lifeskim:mentions | umls-concept:C1140680 | lld:lifeskim |
| pubmed-article:21324516 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21324516 | lifeskim:mentions | umls-concept:C0205281 | lld:lifeskim |
| pubmed-article:21324516 | lifeskim:mentions | umls-concept:C0376571 | lld:lifeskim |
| pubmed-article:21324516 | lifeskim:mentions | umls-concept:C1511024 | lld:lifeskim |
| pubmed-article:21324516 | lifeskim:mentions | umls-concept:C0439603 | lld:lifeskim |
| pubmed-article:21324516 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:21324516 | pubmed:dateCreated | 2011-4-25 | lld:pubmed |
| pubmed-article:21324516 | pubmed:abstractText | The heritable fraction of ovarian cancer exceeds that of any other common adult cancer. Most inherited cases of ovarian cancer are due to a germline mutation in BRCA1 or BRCA2. It is important to have an accurate estimate of the proportion of ovarian cancer patients who carry a mutation and the specific factors which predict the presence of a mutation. | lld:pubmed |
| pubmed-article:21324516 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21324516 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21324516 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21324516 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21324516 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21324516 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21324516 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21324516 | pubmed:month | May | lld:pubmed |
| pubmed-article:21324516 | pubmed:issn | 1095-6859 | lld:pubmed |
| pubmed-article:21324516 | pubmed:author | pubmed-author:NarodSteven... | lld:pubmed |
| pubmed-article:21324516 | pubmed:author | pubmed-author:RischHarvey... | lld:pubmed |
| pubmed-article:21324516 | pubmed:author | pubmed-author:ROSSJ KJK | lld:pubmed |
| pubmed-article:21324516 | pubmed:author | pubmed-author:ZhangShiyuS | lld:pubmed |
| pubmed-article:21324516 | pubmed:author | pubmed-author:McLaughlinJoh... | lld:pubmed |
| pubmed-article:21324516 | pubmed:author | pubmed-author:RosenBarryB | lld:pubmed |
| pubmed-article:21324516 | pubmed:author | pubmed-author:BradleyLindaL | lld:pubmed |
| pubmed-article:21324516 | pubmed:author | pubmed-author:RoyerRobertR | lld:pubmed |
| pubmed-article:21324516 | pubmed:author | pubmed-author:FanIsabelI | lld:pubmed |
| pubmed-article:21324516 | pubmed:author | pubmed-author:ShawPatricia... | lld:pubmed |
| pubmed-article:21324516 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Inc. All rights reserved. | lld:pubmed |
| pubmed-article:21324516 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21324516 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:21324516 | pubmed:volume | 121 | lld:pubmed |
| pubmed-article:21324516 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21324516 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21324516 | pubmed:pagination | 353-7 | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:meshHeading | pubmed-meshheading:21324516... | lld:pubmed |
| pubmed-article:21324516 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21324516 | pubmed:articleTitle | Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. | lld:pubmed |
| pubmed-article:21324516 | pubmed:affiliation | Women's College Research Institute, University of Toronto, 790 Bay Street, 7th Floor, Toronto, ON, Canada M5G 1N8. | lld:pubmed |
| pubmed-article:21324516 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21324516 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21324516 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| entrez-gene:672 | entrezgene:pubmed | pubmed-article:21324516 | lld:entrezgene |
| entrez-gene:675 | entrezgene:pubmed | pubmed-article:21324516 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21324516 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21324516 | lld:entrezgene |
